{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:10:24Z","timestamp":1759191024558,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009874","name":"Regione Autonoma Friuli Venezia Giulia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jbiotec.2020.02.004","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T12:09:04Z","timestamp":1581595744000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Selection and characterization of highly specific recombinant antibodies against West Nile Virus E protein"],"prefix":"10.1016","volume":"311","author":[{"given":"S.","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Imperato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mora-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Konstantinidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4309-242X","authenticated-orcid":false,"given":"D.","family":"Sblattero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2020.02.004_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8040193","article-title":"Current understanding of west nile virus clinical manifestations, immune responses, neuroinvasion, and immunotherapeutic implications","volume":"8","author":"Bai","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0010","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JCM.42.6.2759-2765.2004","article-title":"Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection","volume":"42","author":"Beasley","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nbt.2011.12.005","article-title":"Simple scale-up of recombinant antibody production using an UCOE containing vector","volume":"29","author":"Boscolo","year":"2012","journal-title":"N. Biotechnol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11663-2","article-title":"Viral priming of cell intrinsic innate antiviral signaling by the unfolded protein response","volume":"10","author":"Carletti","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13071-016-1736-6","article-title":"Ecology of West Nile virus across four European countries: review of weather profiles, vector population dynamics and vector control response","volume":"9","author":"Chaskopoulou","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biologicals.2010.07.004","article-title":"Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization","volume":"38","author":"Ch\u00e1vez","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0035","first-page":"13975","article-title":"Localization and characterization of flavivirus envelope glycoprotein","volume":"78","author":"Crill","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4939-8958-4_15","article-title":"Phage display technology for human monoclonal antibodies","volume":"1904","author":"Dal Ferro","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0007747","article-title":"High specificity and sensitivity of Zika EDIIIbased ELISA diagnosis highlighted by a large human reference panel","volume":"13","author":"Denis","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0055","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0060","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1128\/JCM.42.9.4101-4110.2004","article-title":"Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses","volume":"42","author":"Holbrook","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v11090823","article-title":"Twenty years of progress toward west nile virus vaccine development","volume":"11","author":"Kaiser","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v11090823","article-title":"Twenty years of progress toward west nile virus vaccine development","volume":"11","author":"Kaiser","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10096-007-0309-1","article-title":"Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans","volume":"26","author":"Ludolfs","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056469","article-title":"An albumin-derived peptide scaffold capable of binding and catalysis","volume":"8","author":"Luisi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.02421","article-title":"Surveillance and diagnosis of west nile virus in the face of flavivirus cross-reactivity","volume":"9","author":"Lustig","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0090","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jiac.2019.04.003","article-title":"Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis","volume":"25","author":"Maeki","year":"2019","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0095","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1099\/vir.0.031641-0","article-title":"Flavivirus-induced antibody cross-reactivity","volume":"92","author":"Mansfield","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-32401-6","article-title":"West Nile virus transmission and human infection risk in Veneto (Italy): a modelling analysis","volume":"8","author":"Marini","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0105","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","volume":"18","author":"Minke","year":"2004","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0110","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/vbz.2017.2172","article-title":"Differential diagnosis of flavivirus infections in horses using viral envelope protein domain III antigens in enzyme-linked immunosorbent assay","volume":"17","author":"Piyasena","year":"2017","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jviromet.2018.06.016","article-title":"A monoclonal antibody to DIII E protein allowing the differentiation of West Nile virus from other flaviviruses by a lateral flow assay","volume":"260","author":"Rebollo","year":"2018","journal-title":"J. Virol. Methods"},{"issue":"9","key":"10.1016\/j.jbiotec.2020.02.004_bib0135","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/v5092079","article-title":"Ecology of West Nile virus in North America","volume":"5","author":"Reisen","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0140","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ttbdis.2019.04.021","article-title":"A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties","volume":"10","author":"Rizzo","year":"2019","journal-title":"Ticks Tick. Dis."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004218","article-title":"Recombinant envelope-proteins with mutations in the conserved fusion loop allow specific serological diagnosis of dengue-infections","volume":"9","author":"Rockstroh","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0150","first-page":"1701","article-title":"Specific detection and differentiation of tick-borne encephalitis and West Nile virus induced IgG antibodies in humans and horses","volume":"66","author":"Rockstroh","year":"2019","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0155","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3390\/v5102329","article-title":"Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies","volume":"5","author":"Sambri","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/71958","article-title":"Exploiting recombination in single bacteria to make large phage antibody libraries","volume":"18","author":"Sblattero","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jviromet.2009.02.018","article-title":"Cloning and expression of domain III of the envelope gene of Japanese encephalitis virus: evaluation for early clinical diagnosis by IgM ELISA","volume":"158","author":"Shukla","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV virus taxonomy profile: Flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0175","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jbiotec.2020.02.004_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms7070184","article-title":"West nile virus and usutu virus co-circulation in europe: epidemiology and implications","volume":"7","author":"Zannoli","year":"2019","journal-title":"Microorganisms"}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165620300316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165620300316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:51:23Z","timestamp":1759150283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165620300316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"alternative-id":["S0168165620300316"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2020.02.004","relation":{},"ISSN":["0168-1656"],"issn-type":[{"type":"print","value":"0168-1656"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection and characterization of highly specific recombinant antibodies against West Nile Virus E protein","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2020.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}